Showing results (101-110 of 516) with videos related to

Sort By:
Pageof 52
Hematology/Oncology Clinics of North America|July 17, 2012
Role of neurosurgery and radiation therapy in the management of brain tumorsToral R Patel, James B Yu, Joseph M Piepmeier
Clinical Lymphoma, Myeloma & Leukemia|October 9, 2012
Age, race, sex, stage, and incidence of cutaneous lymphomaLynn D Wilson, Ginette A Hinds, James B Yu
Oncology (Williston Park, N.Y.)|May 22, 2024
AI Use in Prostate Cancer: Potential Improvements in Treatments and Patient CareJames B Yu Md Mhs Fastro, Julian C Hong
American Journal of Clinical Oncology|January 21, 2010
Population based cancer registry analysis of primary tracheal carcinomaAlfredo I Urdaneta, James B Yu, Lynn D Wilson
Urology|July 13, 2004
Prospective quality-of-life assessment in patients receiving concurrent gemcitabine and radiotherapy as a bladder preservation strategyJoseph M Herman, David C Smith, James Montie, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2002
The use of preferences to measure the benefit of adjuvant radiation therapy for stage I seminomaJune L Chan, Mohammed U Kabeto, A Elizabeth Oldread, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapyJune L Chan, Susan W Lee, Benedick A Fraass, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2014
Adjuvant and salvage radiotherapy after prostatectomy: American Society of Clinical Oncology clinical practice guideline endorsementStephen J Freedland, R Bryan Rumble, Antonio Finelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Prognostic value of p16 in locally advanced prostate cancer: a study based on Radiation Therapy Oncology Group Protocol 9202Arnab Chakravarti, Michelle DeSilvio, Min Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics|November 8, 2008
Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-risk prostate cancer: preliminary toxicity analysis of RTOG 99-02Seth A Rosenthal, Kyoungwha Bae, Kenneth J Pienta, et al.
Pageof 52